Figure 4
Figure 4. Frequencies and distributions of molecular mutations. Identified mutations and their frequencies in patients annotated according to karyotype by MC and SNP-A (A) and diagnostic criteria of CMML-1, CMML-2, and sAML (B). Most identified mutations were detected in patients with a normal karyotype by MC. SNP-A improved the detection rate, and only 10% of patients with uncovered SNP-A lesions did not carry any mutation. Among these patients an accumulation of mutations was observed (≥ 3 mutations in 19% vs 7% in those without new SNP-A lesions). Additional accumulation of mutations was found in AML derived from CMML compared with CMML-1/2. (C) Systematic mutational sequencing shows almost all possible combinations of genetic states for studied genes in patients with CMML and AML derived from CMML. Of 72 patients, only 14% of patients did not display mutations in any of the studied genes.

Frequencies and distributions of molecular mutations. Identified mutations and their frequencies in patients annotated according to karyotype by MC and SNP-A (A) and diagnostic criteria of CMML-1, CMML-2, and sAML (B). Most identified mutations were detected in patients with a normal karyotype by MC. SNP-A improved the detection rate, and only 10% of patients with uncovered SNP-A lesions did not carry any mutation. Among these patients an accumulation of mutations was observed (≥ 3 mutations in 19% vs 7% in those without new SNP-A lesions). Additional accumulation of mutations was found in AML derived from CMML compared with CMML-1/2. (C) Systematic mutational sequencing shows almost all possible combinations of genetic states for studied genes in patients with CMML and AML derived from CMML. Of 72 patients, only 14% of patients did not display mutations in any of the studied genes.

Close Modal

or Create an Account

Close Modal
Close Modal